Report overview
Cell therapy is the use of stem cells or their derivatives to promote the repair of diseased, dysfunctional or damaged tissue. As technology develops, researchers can grow stem cells in the lab to differentiate into specific types of cells such as heart muscle cells, blood cells or nerve cells. This is a type of cell that helps repair damaged tissues or organs.
This report contains market size and forecasts of Cell Therapy Regenerative Medicine in global, including the following market information:
Global Cell Therapy Regenerative Medicine Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Cell Therapy Regenerative Medicine Market Sales, 2018-2023, 2023-2030, (K Units)
Global top five Cell Therapy Regenerative Medicine companies in 2022 (%)
The global Cell Therapy Regenerative Medicine market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
NK Cell Therapy Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Cell Therapy Regenerative Medicine include DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure and Cellular Dynamics International, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cell Therapy Regenerative Medicine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell Therapy Regenerative Medicine Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Cell Therapy Regenerative Medicine Market Segment Percentages, by Type, 2022 (%)
NK Cell Therapy
CAR-T Cell Therapy
Others
Global Cell Therapy Regenerative Medicine Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Cell Therapy Regenerative Medicine Market Segment Percentages, by Application, 2022 (%)
Dermatology
Cardiovascular
Central Nervous System
Plastic Surgery
Other Medical Applications
Global Cell Therapy Regenerative Medicine Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Cell Therapy Regenerative Medicine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cell Therapy Regenerative Medicine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Cell Therapy Regenerative Medicine revenues share in global market, 2022 (%)
Key companies Cell Therapy Regenerative Medicine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Cell Therapy Regenerative Medicine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
DePuy Synthes
Medtronic
ZimmerBiomet
Stryker
Acelity
MiMedx Group
Organogenesis
UniQure
Cellular Dynamics International
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
Stemcell Technologies
Bellicum Pharmaceuticals
